WithdrawnNot Applicable

Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency

Stopped: Study never started

United States0Started 2016-07

Plain-language summary

To determine the safety profile of sodium fluorescein in women undergoing cystoscopy during gynecologic surgery. To determine if either oral phenazopyridine or sodium fluorescein result in shorter cystoscopy times.

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * \- Patients must be 18 years or older as well as willing and able to provide informed consent * Patients undergoing a scheduled gynecologic procedure with cystoscopy Exclusion Criteria: * \- Patients are younger than 18 years * Patients are unable or unwilling to provide informed consent * Patients with a history of an allergic reaction to sodium fluorescein or phenazopyridine * Patients with a history of renal insufficiency * Patients with a history of liver disease * Patients with a history of sickle cell disease * Patients with a history of glucose-6-phosphate dehydrogenase deficiency * Patients with a history of chronic obstructive pulmonary disease or currently being treated for asthma

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

differences in time that elapses between starting cystoscopy and identifying both ureteral jets between treatment groups

Timeframe: 12 months

Trial details

NCT IDNCT02757417

SponsorUniversity Hospitals Cleveland Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-01

View on ClinicalTrials.gov More Ureteral Injury trials